Business Context and Reporting Period
This Form 6-K filing by Foresight Autonomous Holdings Ltd. (the "Company") covers the month of March 2025, with a report date of March 12, 2025. The filing discloses a strategic investment transaction involving the Company's wholly owned subsidiary, Eye-Net Mobile Ltd. ("Eye-Net").
Key Financial Metrics and Transaction Details
- Investment Amount: Gross proceeds of approximately $2.75 million (before fees and expenses).
- Valuation: Eye-Net pre-money valuation set at $45 million.
- Equity Stake: Investors acquired approximately 5.8% of Eye-Net's ordinary shares.
- Capital Raised Status: $2.1 million closed on March 11, 2025; the remaining balance expected to close on or about March 13, 2025.
- Use of Proceeds: Working capital and general corporate purposes for Eye-Net.
- Warrant Issuance:
- Series A Warrants: Exercise price of $0.01 per ADS (subject to a $0.45 floor); capped at 6,111,111 ADSs.
- Series B Warrants: Exercise price at 125% of the Closing ADS Price; exercisable for 24 months.
Note: The filing does not provide consolidated revenue, profit, cash flow, or debt metrics for the Company or Eye-Net.
Material Changes and Terms
The primary material change is the execution of securities purchase agreements with institutional and private investors. Key terms include:
- Antidilution Protection: Investors receive protection against down rounds within one year, subject to a valuation floor of $30 million.
- Registration Rights: The Company agreed to file a resale registration statement by April 15, 2025, to cover the resale of ADSs issuable upon warrant exercise.
- Regulatory Status: Securities were offered under exemptions (Section 4(a)(2), Rule 506(b), and/or Regulation S) and are not registered under the Securities Act of 1933.
Outlook, Risks, and Contingencies
- Closing Contingencies: The final tranche of the investment is contingent on customary conditions, including regulatory approvals and the accuracy of representations and warranties.
- Liquidity Risk: The warrants are not listed for trade until the registration statement becomes effective.
- Dilution Risk: The issuance of Series A and Series B warrants may result in significant dilution to existing shareholders, particularly given the low exercise price of Series A warrants.
Investor Verification Checklist
- Verify the final closing of the remaining investment balance (approx. $0.65 million) on or after March 13, 2025.
- Confirm the filing of the resale registration statement by the April 15, 2025 deadline.
- Review the specific identities of the institutional and private investors to assess strategic alignment.
- Monitor the Company's ADS trading price to calculate the actual dilution impact of the Series B warrants.
- Check for any subsequent filings regarding the use of proceeds by Eye-Net.